🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseMy liver enzyme journey — ALT from 98 to 19 on semaglutide Page 6

My liver enzyme journey — ALT from 98 to 19 on semaglutide

DerekSJ_a1c Wed, May 27, 2026 at 9:10 AM 29 replies 552 viewsPage 6 of 6
oliver_london
Member
312
1,345
Aug 2024
London, UK
Jun 3, 2026 at 11:28 PM#26

One thing that is still open after andrew_nyc’s answer:

How much of the between-person variation is pharmacokinetic and how much is just adherence measured badly?

1 24Admin
Reply Quote Save Share Report
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Jun 4, 2026 at 11:34 PM#27
lisa_labSD said:
If you are going to change something, change one thing and give it long enough to express itself.

Pushing back on lisa_labSD here. The counter-case has not been addressed. Somebody upthread described the situation that does not fit, and the thread moved on rather than engaging with it, which is the failure mode this board is supposed to avoid.

Last edited: Jun 5, 2026 at 5:34 AM
2 0wei_SG, cory_ATX
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Jun 5, 2026 at 11:38 PM#28
lisa_labSD said:
If you are going to change something, change one thing and give it long enough to express itself.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

Worth separating that from liver and MASH, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

3 1FranDenver, Dr.BariatricHTX, LindaRN_retired
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
Jun 6, 2026 at 11:43 PM#29
lisa_labSD said:
If you are going to change something, change one thing and give it long enough to express itself.

Genuinely useful, thank you. I had the facts and not the framework. I will report back once I have actually tried it.

4 2fiona_VT, denise_HTX, raj_cambridge and 1 other
Reply Quote Save Share Report
DerekSJ_a1c
Member
378
1,678
Aug 2024
San Jose, CA
Jun 7, 2026 at 11:46 PM#30

Reporting back.

Update since I posted: I held at 1.7mg for a further twelve weeks and lost another 4kg slowly, which settles it for me. I was escalating because the number was available, not because I had stopped responding.

26 24AttorneyGrant, DebRD_ATL, KristenIndy and 23 others
Reply Quote Save Share Report
1456

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register